Cure TV

The relationship between a patient and an oncologist needs to be a very open one, says oncologist Heather Wakelee, associate professor of oncology at the Stanford University Medical Center.

Min Li, of the University of Texas Health Sciences Health Science Center in Houston, offers dietary and lifestyle suggestions for newly diagnosed pancreatic cancer patients.

Stuart Goldberg, hematologist/oncologist at John Theurer Cancer Center, discusses some of the common questions he gets from his patients with chronic myeloid leukemia.

When it comes to managing your risk of cancer, especially when dealing with a familial cancer risk, "what is right for one person, may not be right for another," says Amy Byer Shainman.

Debu Tripathy, editor-in-chief of CURE magazine, discusses updates from the Miami Breast Cancer Conference, including the changing landscape of HER2-positive breast cancer.

Debu Tripathy, editor-in-chief of CURE magazine and breast oncologist, discusses genetic testing from the 32nd annual Miami Breast Cancer Conference.

Debu Tripathy, CURE's editor-in-chief, reports on surgical research updates announced at the Miami Breast Cancer Conference held in late February.

The evolution of the treatment for hormone receptor-positive breast cancer was a hot topic for this year's Miami Breast Cancer Conference. Debu Tripathy, CURE's editor-in-chief and breast oncologist, reports from the meeting.

Richard Joseph, assistant professor of medical oncology at Mayo Clinic in Jacksonville, Florida, explains how treatment outcomes for metastatic melanoma have grown in the past few years.

Heather Wakelee, of Stanford University Medical Center, discusses the importance of molecular profiling in predicting the response of EGFR inhibitors for patients with non-small cell lung cancer.

Lung cancer specialist Mark Socinski, at the University of Pittsburgh Cancer Institute, discusses VeriStrat testing and how it may be useful in the diagnosis of non-small cell lung cancer.

Immunotherapies have strong potential as a treatment option for patients with NSCLC, as clinical trials have shown dramatic and durable results.

Anees B. Chagpar, director of the Breast Center at Smilow Cancer Hospital at Yale-New Haven Hospital in Connecticut, discusses why certain patients should receive genetic counseling and testing for breast cancer.

Beth Overmoyer, a breast oncologist at the Susan F. Smith Center for Women's Cancer's at Dana-Farber in Boston, provides a brief overview of inflammatory breast cancer.

Anne Quinn Young, of the Multiple Myeloma Research Foundation, discusses some of the antibodies that are being studied in multiple myeloma.

Michelle Gervino, an oncology nurse with John Theurer Cancer Center, advises patients to communicate with their medical team about any side effects they may be experiencing.

Brian G.M. Durie, an expert in multiple myeloma at Cedars-Sinai in Los Angeles, Calif., and chairman of the International Myeloma Foundation, discusses the ASPIRE trial for patients with relapsed myeloma.

Melanoma specialist, Suzanne L. Topalian discusses how new approved drugs and those in the pipeline for advanced melanoma are making an impact for patient.

Oncologist Anees B. Chagpar sums up the various studies that have looked at lifestyle changes and cancer risk.

Journalist Joan Lunden shares her experience with breast cancer, side effects and working through treatment.

Jenna Forsythe, an oncology nurse at John Theurer Cancer Center in Hackensack, New Jersey, says many patients newly diagnosed with cancer will need to allow themselves to lean on their medical team, especially in regards to symptom management.

Lewis Silverman, an oncologist with Mount Sinai Medical Center, discusses a clinical trial involving Revlimid (lenalidomide) for patients with a type of myelodysplastic syndrome.

Oncology nurse Linda Casey encourages caregivers to be vigilant in watching for signs and symptoms of anything abnormal in the patient, such as certain side effects.

Roy Firestone interviews longtime journalist, author and television host Joan Lunden on her recent breast cancer diagnosis and treatment.

Debbie Zelman is the founder and president of Debbie's Dream Foundation: Curing Stomach Cancer, a nonprofit organization that is dedicated to educating and supporting patients and their families.

Beth Overmoyer, a breast oncologist at Dana-Farber Cancer Institute, speaks on the results of the SOFT trial and its potential impact on young women with hormone receptor-positive breast cancer.

Raoul Concepcion, a urologist with Urology Associates in Nashville, Tenn., explains Gleason score and Gleason grade as it relates to a prostate cancer diagnosis.

Project Innovation is a consortium led by the National Patient Advocate Foundation to raise public awareness about the need to accelerate the delivery of new treatments to patients.